Pro

Date 29 September 2014
Event ESMO 2014
Session Docetaxel is the standard of care for metastatic prostate cancer patients starting Androgen deprivation therapy (ADT)
Topics Anticancer agents
Prostate Cancer
Therapy
Biological Therapy
Presenter Karim Fizazi
Authors K. Fizazi
  • Department Of Cancer Medicine, Institut Gustave Roussy, 94805 - Villejuif/FR